News
Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...
1h
Medindia on MSNIndia Takes Historic Step With First Gene Therapy for HemophiliaGene therapy marks India's first major leap in treating hemophilia * Biotechnology sector grows to over 165 billion dollars, ...
Announce initial clinical data from Cohort 1 in the Phase 1/2 trial of PM359 for p47 phox CGD in 2025. The initial readout ...
A group of experts cautions that the lack of specific rules for genome-edited crops may hurt transparency, while the ...
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced ...
A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...
To stay ahead, Hong Kong focuses on talent acquisition and retention. The Research Talent Hub under the Innovation and ...
Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...
The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...
A recent study marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. As a proof-of-concept, the ...
Late last year, the therapy developers dosed their first patient following positive preclinical data demonstrating safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results